Cargando…
Diagnostic value of [(18)F]FDG PET/MRI for staging in patients with ovarian cancer
PURPOSE: To evaluate the diagnostic potential of PET/MRI with 2-[(18)F]fluoro-2-deoxy-d-glucose ([(18)F]FDG) in ovarian cancer. MATERIALS AND METHODS: Participants comprised 103 patients with suspected ovarian cancer underwent pretreatment [(18)F]FDG PET/MRI, contrast-enhanced CT (ceCT) and pelvic d...
Autores principales: | Tsuyoshi, Hideaki, Tsujikawa, Tetsuya, Yamada, Shizuka, Okazawa, Hidehiko, Yoshida, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532239/ https://www.ncbi.nlm.nih.gov/pubmed/33006685 http://dx.doi.org/10.1186/s13550-020-00712-3 |
Ejemplares similares
-
Diagnostic value of (18)F-FDG PET/MRI for staging in patients with endometrial cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020) -
Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021) -
Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging
por: Isaji, Yuzu, et al.
Publicado: (2023) -
(18)F-FDG/(18)F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma
por: Yamamoto, Makoto, et al.
Publicado: (2017) -
Integrated [(18)F]FDG PET/MRI demonstrates the iron-related bone-marrow physiology
por: Tsujikawa, Tetsuya, et al.
Publicado: (2020)